Cargando…

World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland

OBJECTIVES: To explore and reflect on the current anticoagulation therapy offered to patients with atrial fibrillation (AF), potential challenges and the future vision for oral anticoagulants for patients with AF and healthcare professionals in Ireland. DESIGN: A multistakeholder focus group using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Aileen, Brosnan, Stephen, McCarthy, Stephen, O’Raghallaigh, Paidi, Bradley, Colin, Kirby, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517561/
https://www.ncbi.nlm.nih.gov/pubmed/32973054
http://dx.doi.org/10.1136/bmjopen-2019-036493
_version_ 1783587254194667520
author Murphy, Aileen
Brosnan, Stephen
McCarthy, Stephen
O’Raghallaigh, Paidi
Bradley, Colin
Kirby, Ann
author_facet Murphy, Aileen
Brosnan, Stephen
McCarthy, Stephen
O’Raghallaigh, Paidi
Bradley, Colin
Kirby, Ann
author_sort Murphy, Aileen
collection PubMed
description OBJECTIVES: To explore and reflect on the current anticoagulation therapy offered to patients with atrial fibrillation (AF), potential challenges and the future vision for oral anticoagulants for patients with AF and healthcare professionals in Ireland. DESIGN: A multistakeholder focus group using a World Café approach. PARTICIPANTS: Nine participants from academic, clinical and health backgrounds attended the focus group together with a facilitator. RESULTS: Enhanced patient empowerment; more effective use of technology and developing system-based medical care pathways would provide improved supports for AF management. The challenges in providing these include cost and access issues, the doctor–patient relationship and the provision of education. While consensus for developing evidence-based pathways to maximise efficiency and effectiveness of AF treatment was evident, it would require a shared vision between stakeholders of integrated care. The benefits of embracing technological advances for clinicians and patients were evident; however, clinicians indicate this can increase pressure on already stretched resources; coupled with institutional barriers (including scarce resources) arising from the complex nature of anticoagulation for patients with AF, which emerged strongly. Including the unpredictable nature of warfarin, hidden costs associated with monitoring, adverse clinical effects, different patient cohorts (including those prescribed anticoagulant for the first time vs those switching from warfarin to a new oral anticoagulant (NOAC)), non-adherence concerns and undesirable impacts on patients’ daily lives. CONCLUSIONS: While anticoagulation therapy for patients with AF using NOACs has been widely adopted and is diffusing into routine practice, significant operationalisation issues and barriers to effective treatment/management persist. The reflections reported in this study are a catalyst for future discussion and research.
format Online
Article
Text
id pubmed-7517561
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75175612020-10-05 World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland Murphy, Aileen Brosnan, Stephen McCarthy, Stephen O’Raghallaigh, Paidi Bradley, Colin Kirby, Ann BMJ Open Cardiovascular Medicine OBJECTIVES: To explore and reflect on the current anticoagulation therapy offered to patients with atrial fibrillation (AF), potential challenges and the future vision for oral anticoagulants for patients with AF and healthcare professionals in Ireland. DESIGN: A multistakeholder focus group using a World Café approach. PARTICIPANTS: Nine participants from academic, clinical and health backgrounds attended the focus group together with a facilitator. RESULTS: Enhanced patient empowerment; more effective use of technology and developing system-based medical care pathways would provide improved supports for AF management. The challenges in providing these include cost and access issues, the doctor–patient relationship and the provision of education. While consensus for developing evidence-based pathways to maximise efficiency and effectiveness of AF treatment was evident, it would require a shared vision between stakeholders of integrated care. The benefits of embracing technological advances for clinicians and patients were evident; however, clinicians indicate this can increase pressure on already stretched resources; coupled with institutional barriers (including scarce resources) arising from the complex nature of anticoagulation for patients with AF, which emerged strongly. Including the unpredictable nature of warfarin, hidden costs associated with monitoring, adverse clinical effects, different patient cohorts (including those prescribed anticoagulant for the first time vs those switching from warfarin to a new oral anticoagulant (NOAC)), non-adherence concerns and undesirable impacts on patients’ daily lives. CONCLUSIONS: While anticoagulation therapy for patients with AF using NOACs has been widely adopted and is diffusing into routine practice, significant operationalisation issues and barriers to effective treatment/management persist. The reflections reported in this study are a catalyst for future discussion and research. BMJ Publishing Group 2020-09-24 /pmc/articles/PMC7517561/ /pubmed/32973054 http://dx.doi.org/10.1136/bmjopen-2019-036493 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiovascular Medicine
Murphy, Aileen
Brosnan, Stephen
McCarthy, Stephen
O’Raghallaigh, Paidi
Bradley, Colin
Kirby, Ann
World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
title World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
title_full World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
title_fullStr World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
title_full_unstemmed World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
title_short World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
title_sort world café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (af) in ireland
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517561/
https://www.ncbi.nlm.nih.gov/pubmed/32973054
http://dx.doi.org/10.1136/bmjopen-2019-036493
work_keys_str_mv AT murphyaileen worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland
AT brosnanstephen worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland
AT mccarthystephen worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland
AT oraghallaighpaidi worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland
AT bradleycolin worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland
AT kirbyann worldcafeapproachexploringthefuturevisionoforalanticoagulantsforpatientswithatrialfibrillationafinireland